J Tradit Chin Med. 2013 Dec;33(6):721-6. doi: 10.1016/s0254-6272(14)60003-0.
This is a review of the effects of Chinese herbal medicine (CHM) used alone to treat lumbar disc herniation (LDH).
A literature search of the following electronic databases from their inception to February 2013 was conducted: Chinese Biomedical databases, Chinese National Knowledge Infrastructure, Wanfang Database, China Science and Technology Journal Database, Cochrane Library, Web of Science, MEDLINE, and EMBASE. Randomized controlled trials where CHM had been used to treat LDH were selected. Data extraction, quality assessment, and data analysis were carried out by two independent reviewers.
Of the 2415 studies identified, eight with complete data on 1146 patients were selected. The methodological quality was poor in all trials. Five studies reported that CHM was better than Western Medicine [OR = 2.81, 95% CI (1.27, 6.18); OR = 3.34, 95% CI (1.92, 5.79); OR = 2.22, 95% CI (1.08, 4.57); OR = 6.67, 95% CI (1.34, 33.28); and OR = 1.94, 95% CI (1.23, 3.06)]. Two studies reported that the clinical outcome was better in CHM groups than in physiotherapy and placebo groups, [OR = 3.02, 95% CI (1.08, 8.46); and OR = 2.67, 95% CI (1.26, 5.64), respectively], whereas one study reported no difference between CHM and physiotherapy groups. One study reported that CHM resulted in higher Japanese Orthopedic Association scores [MD = 7.78, 95% CI (6.67, 8.89)] than in a control group and another that participants treated with CHM had lower Visual Analogue Scale scores [MD = -0.72, 95% CI (- 0.86, -0.58)] than those in a control group. Three studies reported that the adverse effects of CHM and Western Medicine did not differ significantly [OR = 0.10, 95% Cl (0.01, 1.85); OR = 0.19, 95% CI (0.01, 4.07); and OR = 0.07, 95% CI (0.00, 1.32)].
CHM may be more effective than other interventions for LDH; however, methodological weaknesses in the studies assessed in this review prevent a definitive conclusion. More high-quality large-scale studies are required to clarify this matter.
本研究旨在综述单独应用中草药(CHM)治疗腰椎间盘突出症(LDH)的效果。
检索中国生物医学文献数据库、中国知网、万方数据知识服务平台、中国科技期刊数据库、Cochrane 图书馆、Web of Science、MEDLINE 和 EMBASE 自成立至 2013 年 2 月的相关文献,纳入单独应用 CHM 治疗 LDH 的随机对照试验。由 2 位评价者独立进行数据提取、质量评价和资料分析。
共检索到 2415 篇文献,最终纳入 8 项研究,共计 1146 例患者。所有研究方法学质量均较低。5 项研究表明 CHM 优于西药[比值比(OR)=2.81,95%可信区间(CI)(1.27,6.18);OR=3.34,95%CI(1.92,5.79);OR=2.22,95%CI(1.08,4.57);OR=6.67,95%CI(1.34,33.28);OR=1.94,95%CI(1.23,3.06)]。2 项研究表明 CHM 组的临床疗效优于物理疗法组和安慰剂组[OR=3.02,95%CI(1.08,8.46);OR=2.67,95%CI(1.26,5.64)],1 项研究表明 CHM 组与物理疗法组之间差异无统计学意义。1 项研究报道 CHM 组日本骨科协会(JOA)评分[均数差(MD)=7.78,95%CI(6.67,8.89)]高于对照组,另 1 项研究报道 CHM 组视觉模拟评分[MD=-0.72,95%CI(-0.86,-0.58)]低于对照组。3 项研究报道 CHM 与西药的不良反应发生率差异无统计学意义[OR=0.10,95%CI(0.01,1.85);OR=0.19,95%CI(0.01,4.07);OR=0.07,95%CI(0.00,1.32)]。
与其他干预措施相比,CHM 可能对 LDH 更有效,但本研究纳入的研究方法学质量均较低,无法得出明确结论。需要更多高质量的大样本研究来阐明这一问题。